Terms: = Sarcomas AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463
12 results:
1. The studies of rita Levi-Montalcini on the effects of tumor transplantation on the chorioallantoic membrane.
Ribatti D
Clin Anat; 2022 May; 35(4):537-541. PubMed ID: 35293036
[TBL] [Abstract] [Full Text] [Related]
2. Genomic Landscape of Malignant Peripheral Nerve Sheath Tumor‒Like Melanoma.
Muniz TP; Sorotsky H; Kanjanapan Y; Rose AAN; Araujo DV; Fortuna A; Ghazarian D; Kamil ZS; Pugh T; Mah M; Thiagarajah M; Torti D; Spreafico A; Hogg D
J Invest Dermatol; 2021 Oct; 141(10):2470-2479. PubMed ID: 33831431
[TBL] [Abstract] [Full Text] [Related]
3. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study.
Zhang C; Guo X; Xu Y; Han X; Cai J; Wang X; Wang G
Sao Paulo Med J; 2019; 137(5):423-429. PubMed ID: 31939567
[TBL] [Abstract] [Full Text] [Related]
4. rita downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
[TBL] [Abstract] [Full Text] [Related]
5. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
[TBL] [Abstract] [Full Text] [Related]
6. IGF-1R/MDM2 relationship confers enhanced sensitivity to rita in Ewing sarcoma cells.
Di Conza G; Buttarelli M; Monti O; Pellegrino M; Mancini F; Pontecorvi A; Scotlandi K; Moretti F
Mol Cancer Ther; 2012 Jun; 11(6):1247-56. PubMed ID: 22461661
[TBL] [Abstract] [Full Text] [Related]
7. Pharmacological activation of a novel p53-dependent S-phase checkpoint involving CHK-1.
Ahmed A; Yang J; Maya-Mendoza A; Jackson DA; Ashcroft M
Cell Death Dis; 2011 May; 2(5):e160. PubMed ID: 21593792
[TBL] [Abstract] [Full Text] [Related]
8. [Potential advantages of the MRI for the radiofrequency ablation of liver tumors].
Gaffke G; Gebauer B; Gnauck M; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Rofo; 2005 Jan; 177(1):77-83. PubMed ID: 15657824
[TBL] [Abstract] [Full Text] [Related]
9. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract] [Full Text] [Related]
10. Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms.
Berber E; Herceg NL; Casto KJ; Siperstein AE
Surg Endosc; 2004 Mar; 18(3):390-6. PubMed ID: 14735342
[TBL] [Abstract] [Full Text] [Related]
11. Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on.
Bennet MR; Gibson WG; Lemon G
Auton Neurosci; 2002 Jan; 95(1-2):1-23. PubMed ID: 11871773
[TBL] [Abstract] [Full Text] [Related]
12. Laparoscopic radiofrequency ablation of primary and metastatic liver tumors. Technical considerations.
Siperstein A; Garland A; Engle K; Rogers S; Berber E; String A; Foroutani A; Ryan T
Surg Endosc; 2000 Apr; 14(4):400-5. PubMed ID: 10790563
[TBL] [Abstract] [Full Text] [Related]
